Achiko AG (XSWX:ACHI) Net Margin % : 0.00% (As of Jun. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Achiko AG's Net Income for the six months ended in Jun. 2022 was CHF-2.42 Mil. Achiko AG's Revenue for the six months ended in Jun. 2022 was CHF0.00 Mil. Therefore, Achiko AG's net margin for the quarter that ended in Jun. 2022 was 0.00%.

The historical rank and industry rank for Achiko AG's Net Margin % or its related term are showing as below:

XSWX:ACHI's Net Margin % is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 1.765
* Ranked among companies with meaningful Net Margin % only.

Achiko AG Net Margin % Historical Data

The historical data trend for Achiko AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Net Margin % Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Net Margin %

-113.13

-501.36

-14,803.45

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Net Margin %	Get a 7-Day Free Trial			-186.61	-8,717.39	-13,241.18	-17,469.57	-

Competitive Comparison of Achiko AG's Net Margin %

For the Health Information Services subindustry, Achiko AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achiko AG's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Achiko AG's Net Margin % falls into.

Achiko AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Achiko AG's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Net Margin	=	Net Income (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-8.586	/	0.058
	=	-14,803.45 %

Achiko AG's Net Margin for the quarter that ended in Jun. 2022 is calculated as

Net Margin	=	Net Income (Q: Jun. 2022 )	/	Revenue (Q: Jun. 2022 )
	=	-2.422	/	0
	=	%

Achiko AG (XSWX:ACHI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Achiko AG Net Margin % Related Terms

Thank you for viewing the detailed overview of Achiko AG's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (XSWX:ACHI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines